Sort
48,018 grants matching “immunotherapy”
TRIAL/ EFFICACY OF IMMUNOTHERAPIES TO CONTROL PLASMA HIV RNA INTERRUP HAART
$469,410Weill Medical College Of Cornell Univ · M01 · FY2005 · RR
Cancer Immunology Training Grant
$469,385Kai W Wucherpfennig · Dana-Farber Cancer Inst · T32 · FY2019 · CA
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer
$469,334Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
$469,327Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2025 · CA
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer
$469,225Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2021 · CA
Peptide Vaccine To Prevent CMV Disease After HSCT
$469,211Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2006 · CA
Peptide Vaccine To Prevent CMV Disease After HSCT
$469,182City Of Hope/Beckman Research Institute · R01 · FY2005 · CA
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
$469,115Robert David Schreiber · Washington University · R01 · FY2015 · CA
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling
$469,080Casey S Greene · University Of Colorado Denver · R01 · FY2024 · CA
Core B - Cell Engineering and Manufacturing Facility
$469,079Donald L Siegel · University Of Pennsylvania · P01 · FY2023 · CA
Identification of Chemical Probes for the Orphan Nuclear Receptor NR2F6
$469,049Laura A Solt · Scripps Florida · R01 · FY2020 · CA
Biology and Immunotherapy of iNKT Cells
$469,026Robert S Negrin · Stanford University · P01 · FY2025 · CA
Discovery of potent human antibodies for prevention of (recurrent) HCV infection
$469,013Mansun Law · Scripps Research Institute, The · R01 · FY2010 · AI
DEVELOPMENTAL FUNDS
$468,982Herbert Kim Lyerly · Duke University · P30 · FY2008 · CA
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$468,979Periasamy Selvaraj · Emory University · R01 · FY2019 · CA
ALDH Inhibition as Modulator of Tumor Immunobiology
$468,896Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2020 · CA
Molecular Mechanisms of Bladder Cancer Immunometabolism
$468,881Liuqing Yang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Exploiting a novel regulator of immunometabolism to enhance immunotherapy
$468,859Edward John Usherwood · Dartmouth College · R01 · FY2024 · CA
Non-Human Primate and Imaging Core
$468,855Francois J Villinger · Northwestern University At Chicago · P01 · FY2019 · AI
Peptide Vaccine To Prevent CMV Disease After HSCT
$468,767Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA
Neoadjuvant checkpoint blockade for recurrent glioblastoma
$468,752Robert M Prins · University Of California Los Angeles · R01 · FY2024 · CA
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
$468,554Jay K Kolls · Tulane University Of Louisiana · R01 · FY2025 · AI
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses
$468,522Benjamin George Keselowsky · University Of Florida · R01 · FY2018 · DE
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$468,519Jin Chen · Vanderbilt University Medical Center · R01 · FY2024 · CA
Targeting the innate immune response in HNSCC
$468,514Judith A. Varner · University Of California, San Diego · R01 · FY2019 · DE